Mad2β, an alternative variant of Mad2 reducing mitotic arrest and apoptosis induced by adriamycin in gastric cancer cells

Life Sciences

Volumn 78, Issue 12, 2006, Pages 1277-1286

  Yin, Fang ^a   Du, Yulei ^a   Hu, Wenhua ^a   Qiao, Taidong ^a   Ding, Jie ^a   Wu, Kaichun ^a   Liu, Zhiguo ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adriamycin; Alternative splicing; Apoptosis; Gastric cancer; Mitotic arrest deficient protein 2; Mitotic checkpoint; Multidrug resistance

Indexed keywords

DOXORUBICIN; MITOMYCIN; PROTEIN MAD2; PROTEIN MAD2 BETA; UNCLASSIFIED DRUG; VINCRISTINE; ANTINEOPLASTIC ANTIMETABOLITE; CALCIUM BINDING PROTEIN; CELL CYCLE PROTEIN; MAD2L1 PROTEIN, HUMAN; RECOMBINANT PROTEIN; REPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PROCESSING; STOMACH CANCER; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; CELL CYCLE; CHEMISTRY; DRUG EFFECT; DRUG RESISTANCE; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENETICS; METABOLISM; MITOSIS; MOLECULAR GENETICS; STOMACH TUMOR; TUMOR CELL LINE;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BASE SEQUENCE; CALCIUM-BINDING PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; MITOSIS; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; STOMACH NEOPLASMS; TRANSFECTION; VARIATION (GENETICS);

EID: 32044446494     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.06.034     Document Type: Article

References (30)

1. H.Z. An, S.J. Zhou, and D.M. Fan Establishment and characteristics of an adriamycin resistant human gastric cancer cell line Journal of Digestive Diseases Endoscopy 2 1 1997 108 110
2. D.J. Burke Complexity in the spindle checkpoint Current Opinion in Genetics and Development 10 1 2000 26 31
3. D.P. Cahill, C. Lengauer, J. Yu, G.J. Riggins, J.K. Willson, S.D. Markowitz, and K.W. Kinzler Mutations of mitotic checkpoint genes in human cancers Nature 392 6673 1998 300 303
4. X.J. Cai, X.Y. Zhang, and D.M. Fan Establishment of multidrug resistant gastric cancer cell line and its biological characteristics Chinese Journal of Clinical Oncology 2S 1994 67 71
5. H.W. Cheung, D.Y. Jin, M.T. Ling, Y.C. Wong, Q. Wang, S.W. Tsao, and X. Wang Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells Cancer Research 65 4 2005 1450 1458
6. A. Gemma, Y. Hosoya, M. Seike, K. Uematsu, F. Kurimoto, S. Hibino, A. Yoshimura, M. Shibuya, S. Kudoh, and M. Emi Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancers Lung Cancer 32 3 2001 289 295
7. E. Hernando, I. Orlow, V. Liberal, G. Nohales, R. Benezra, and C. Cordon-Cardo Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer International Journal of Cancer 95 4 2001 223 227
8. Y. Imai, Y. Shiratori, N. Kato, T. Inoue, and M.J. Omata Mutational inactivation of mitotic checkpoint genes, hsMAD2 and hBUB1, is rare in sporadic digestive tract cancers Cancer Research 90 8 1999 837 840
9. M.A. Jordan, and L. Wilson Microtubules as a target for anticancer drugs Nature Reviews. Cancer 4 4 2004 253 265
10. T. Kasai, Y. Iwanaga, H. Iha, and K.T. Jeang Prevalent loss of mitotic spindle checkpoint in adult T-cell leukemia confers resistance to microtubule inhibitors Journal of Biological Chemistry 277 7 2002 5187 5193
11. A. Kienitz, C. Vogel, I. Morales, R. Muller, and H. Bastians Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol Oncogene 24 26 2005 4301 4310
12. Y. Li, and R. Benezra Identification of a human mitotic checkpoint gene: hsMAD2 Science 274 5285 1996 246 248
13. A. Masuda, K. Maeno, T. Nakagawa, H. Saito, and T. Takahashi Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers American Journal of Pathology 163 3 2003 1109 1116
14. K. Nasmyth Segregating sister genomes: the molecular biology of chromosome separation Science 297 5581 2002 559 565
15. M.J. Percy, K.A. Myrie, C.K. Neeley, J.N. Azim, S.P. Ethier, and E.M. Petty Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells Genes, Chromosomes, and Cancer 29 4 2000 356 362
16. K.X. Shi Epidemiology of gastric cancer Chinese Journal of Gastroenterology 7 3 2002 166 167
17. P. Stoilov, R. Daoud, O. Nayler, and S. Stamm Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA Human Molecular Genetics 13 5 2004 509 524
18. T. Sudo, M. Nitta, H. Saya, and N.T. Ueno Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint Cancer Research 64 7 2004 2502 2508
19. A. Sureau, R. Gattoni, Y. Dooghe, J. Stevenin, and J. Soret SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs EMBO Journal 20 7 2001 1785 1796
20. T. Takahashi, N. Haruki, S. Nomoto, A. Masuda, S. Saji, H. Osada, and T. Takahashi Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers Oncogene 18 30 1999 4295 4300
21. S.S. Taylor, and F. McKeon Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage Cell 89 5 1997 727 735
22. C. Vogel, A. Kienitz, R. Muller, and H. Bastians The mitotic spindle checkpoint is a critical determinant for topoisomerase-based chemotherapy Journal of Biological Chemistry 280 6 2005 4025 4028
23. K. Wassmann, and R. Benezra Mitotic checkpoints: from yeast to cancer Current Opinion in Genetics and Development 11 1 2001 83 90
24. X. Wang, D.Y. Jin, Y.C. Wong, A.L. Cheung, A.C. Chun, A.K. Lo, Y. Liu, and S.W. Tsao Correlation of defective mitotic checkpoint with aberrantly reduced expression of MAD2 protein in nasopharyngeal cancer cells Carcinogenesis 21 12 2000 2293 2297
25. X. Wang, D.Y. Jin, R. Ng, W.H. Feng, Y.C. Wong, A.L. Cheung, and S.W. Tsao Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells Cancer Research 62 6 2002 1662 1668
26. D.H. Weitzel, and D.D. Vandre Differential spindle assembly checkpoint response in human lung adenocarcinoma cells Cell and Tissue Research 300 1 2000 57 65
27. F. Yin, Y.Q. Shi, W.P. Zhao, B. Xiao, J.Y. Miao, and D.M. Fan Suppression of P-gp induced multiple drug resistance in a drug resistant gastric cancer cell line by overexpression of Fas World Journal of Gastroenterology 6 5 2000 664 670
28. F. Yin, T.D. Qiao, Y.Q. Shi, B. Xiao, B.J. Chen, J.Y. Miao, and D.M. Fan In situ hybridization of tight junction molecule occludin mRNA in gastric cancer Chinese Journal of Oncology 24 6 2002 557 560
29. F. Yin, W.H. Hu, T.D. Qiao, and D.M. Fan Multidrug resistant effect of alternative splicing form of MAD2 gene-MAD2b on human gastric cancer cell Chinese Journal of Oncology 26 4 2004 201 204
30. Y. Zhao, H. You, F. Liu, H.Z. An, Y. Shi, Q. Yu, and D. Fan Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells Cancer Letters 185 2 2002 211 218